Skip to main content


Intended Learners

This conference is designed for physicians, nurse practitioners, physician assistants, nurses, and podiatrists across all practice settings involved in the prevention, treatment, and management of patients with diabetic foot complications. 

Learning Objectives

After completing this activity, participants should be able to:

  • Describe the magnitude of diabetic foot complications and apply comprehensive, multidisciplinary best practice approaches for evaluation and treatment  
  • Examine the etiology of diabetic foot ulcers, risk factors, causal pathways, and prevention and management strategies 
  • Review the history, clinical evaluation, and treatment for painless and painful diabetic neuropathy, PAD, and diabetic foot infections 
  • Analyze the pathology, classification, biomarkers, and medical and surgical treatments for charcot foot 
  • Navigate interactive clinical cases of complex diabetic foot problems 

Activity Overview

The second annual Great Debates & Updates (GDU) in Diabetic Foot takes place November 30 - December 2, 2023 in Dallas, TX!  This accredited program offers professionals who treat diabetic foot syndrome the opportunity to debate the most controversial topics in treatment options and gain knowledge from one another.  Led by the following experts, this course will also allow attendees to connect with expert faculty, colleagues, and industry for discussion that will drive patient care forward.

To be eligible for documentation of credit for each session attended, participants must participate in the activity and complete the online general survey and the online evaluation by February 2, 2024. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.  

For questions regarding this activity, please email

Accreditation Statements

IMAGE.pngIn support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.


HMP Education designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This continuing nursing education activity awards 6.0 contact hour(s). 

Provider approved by the California Board of Registered Nursing, Provider #13255 for 6.0 contact hour(s).


American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 CreditsTM from organizations accredited by the ACCME.


APA logoHMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit(s) for activities planned in accordance with the AAPA CME Criteria. This live activity is designated for 6.0 AAPA Category 1 credit(s). PAs should only claim credit commensurate with the extent of their participation.


HMP Education is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine.  HMP Education has approved this internet live activity for a maximum of 6.0 continuing education contact hour(s).

Use of Proprietary Names

This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

Unapproved and/or Investigational Uses of Drugs and Devices

This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of HMP Education.


The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a provider-patient relationship. Medical advice of any nature should be sought from an individual’s own health care provider.

The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Global or any of its subsidiaries or affiliates. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

ADA Statement

HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity needs accommodation(s), please call 609-371-1137.

Privacy Policy

HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Grievance Policy

Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education may contact Samantha Conforti, Senior Manager, Accreditation and Compliance, by phone at 609-371-1137, by email at or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Conforti will review the grievance and respond within 30 days of receiving the complaint.

Commercial Support

The following companies have provided educational grants in support of this activity: Averitas, Defender Ops/Next Science, Kerecis, LifeNet Health, Medtronic, MiMedx, MTF Biologics, Nevro Corp., Organogenesis Inc, Orpyx®. and Smith & Nephew.

Copyright © 2023 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.